Medical device industry rises to challenges of 21st century
This article was originally published in Clinica
Executive Summary
The landscape in which the medical device industry operates has changed beyond all recognition over the last decade. Healthcare reform and cost-containment pressures the world over have unleashed an assault on sales, while rising expenditure on R&D has forced up overheads.
You may also be interested in...
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.